Form 4 for NAGE Niagen Bioscience, Inc.

Accepted 2022-06-21 00:00:00 ET · period of report 2022-06-16 · accession 0000899243-22-023253 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2022-06-21	2022-06-16	NAGE	Chau Hoi Shuen Solina Holly	10%	P - Purchase	$1.66	+60.0K	6.93M	+0.9%	+$99.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-06-16	P	A	60,037	$1.66	6,925,641	I See Footnotes	—	—	(F1) Skyinvest Associates Limited ("Skyinvest Associates") acquired 60,037 shares of the Issuer's common stock in open market purchases on June 16, 2022. (F2) Of the total shares beneficially owned following the reported transaction (i) 5,957,783 shares of the Issuer's common stock are held directly by Pioneer Step Holdings Limited ("Pioneer Step"), (ii) 420,000 shares of the Issuer's common stock are held directly by Dvorak International Limited ("Dvorak International"), and (iii) 547,858 shares of the Issuer's common stock are held directly by Skyinvest Associates. Chau Hoi Shuen Solina Holly ("Solina Chau") is the sole shareholder of each of Pioneer Step and Dvorak International, and Skyinvest Associates is wholly-owned by Solina Chau through intermediate entities that are directly or indirectly wholly-owned by Solina Chau. (F3) (continued from Footnote 2) As such, Solina Chau may be deemed to beneficially own the shares of the Issuer's common stock directly held by Pioneer Step, Dvorak International and Skyinvest Associates. Solina Chau disclaims Section 16 beneficial ownership of the securities held by each of Pioneer Step, Dvorak International and Skyinvest Associates, except to the extent of her pecuniary interest therein, if any.